Quantedge Capital’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-881,900
Closed -$29.1M 68
2025
Q1
$29.1M Buy
881,900
+824,000
+1,423% +$26.9M 9.21% 1
2024
Q4
$1.67M Buy
+57,900
New +$1.66M 0.61% 50
2022
Q4
Sell
-48,400
Closed -$1.08M 171
2022
Q3
$1.08M Sell
48,400
-81,900
-63% -$2.13M 0.33% 84
2022
Q2
$3.88M Buy
+130,300
New +$3.74M 0.78% 44
2022
Q1
Sell
-26,600
Closed -$619K 217
2021
Q4
$619K Buy
+26,600
New +$699K 0.26% 101

Other funds holding ALKS

Quantedge Capital's ALKS Position: Q2 2025 in Review

Quantedge Capital sold out of Alkermes (ALKS) in Q2 2025, closing a stake of 881,900 shares — an estimated $29.1M sold.

Quantedge Capital first reported a position in ALKS in Q4 2021 and held it in 5 quarters. The position peaked at $29.1M in Q1 2025. 353 funds tracked by Wall St. Rank hold ALKS as of Q2 2025.

  • Quantedge Capital reported no remaining Alkermes position as of Q2 2025 after selling out during the quarter.
  • Quantedge Capital sold 881,900 Alkermes shares in Q2 2025, an estimated $29.1M.
  • Quantedge Capital first reported a position in Alkermes in Q4 2021 and held it in 5 quarters.
  • Quantedge Capital's Alkermes position peaked at $29.1M in Q1 2025.
  • 353 funds tracked by Wall St. Rank held Alkermes as of Q2 2025.

Based on Quantedge Capital's 13F filing for Q2 2025, filed 14 Aug 2025.